Bibliografia
POLICO

  1. Mas R., Policosanol, Drugs of the future, 2000, 25 (6), 569-586.

  2. Menedez R. et al., Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts, Arch. Med. Res. 2001, 32, (1), 8-12.

  3. McCarty M.F., Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen, Med. Hypotheses 2002, 59(3), 268-279.

  4. Grundy et al., New Engl. J. Med. 1988, 24, 319; Endo et al., J. Lipid Res. 1992, 33, 1569).

  5. Menendez R. et al., Effects of policosanol treatment on the susceptibility of low density lipoprotein isolated from healthy volunteers to oxidate modification in vitro, Brit. J. Clin. Pharmacol. 2000, 50, (3), 255-262.

  6. Canetti M. et al., Effects of policosanol on primary hypercholesterolemia: a 3-year open-extension follow-up, Curr. Ther. Res. 1997, 58 (11), 868-875.

  7. Hernandez F. et al., Effect of policosanol on serum lipids and lipoproteins in healthy volunteers., Curr. Ther. Res. 1992, 51(4), 568-575.

  8. Gouni-Berthold I. et al., Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am. Heart J. 2002, 143(2), 356-365.

  9. Thorsteinsdottir H. et al., Cuba innovation through synergy, Nature Biotech. 2004, 22, 19-24.

  10. Singh, Dev K.; Li, Li; Porter, Todd D Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase for Pharmacology and Experimental Therapeutics, 2006, 318(3), 1020-26.

  11. Rodrfguez C, Mesa R., Mas R., Noa M. et al., Effects of policosanol chronically administered in male monkeys (Macaca Arctoides) Food Chemical Toxicology, 1994, 32 (6), 565-575,.

  12. Mas R., Noa M. et al., Protective effect of Policosanol on atherosclerotic plaque on aortas in monkeys, Arch Med Res, 2005, 36, 441-44.